Page last updated: 2024-09-05

lenalidomide and Immune System Diseases

lenalidomide has been researched along with Immune System Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bisconte, MG; Bossio, S; Caruso, N; De Stefano, L; Franzese, S; Gentile, C; Gentile, M; Gigliotti, V; Lucia, E; Madeo, A; Mazzone, C; Morabito, F; Morabito, L; Recchia, AG; Servillo, P; Vigna, E1

Reviews

1 review(s) available for lenalidomide and Immune System Diseases

ArticleYear
Lenalidomide in the treatment of chronic lymphocytic leukemia.
    Expert opinion on investigational drugs, 2011, Volume: 20, Issue:2

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Combined Modality Therapy; Humans; Immune System Diseases; Immunologic Factors; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Thalidomide; Tumor Microenvironment

2011
chemdatabank.com